Stockwinners Market Radar for January 10, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:00 EST Hutchmed announces NDA acceptance in China for sovleplenib - Hutchmed announced that the New Drug Application for sovleplenib for the treatment of adult patients with primary immune thrombocytopenia has been accepted for review and granted priority review by the China National Medical Products Administration. Sovleplenib is a novel, selective, oral inhibitor targeting spleen tyrosine kinase, being developed for the treatment of hematological malignancies and immune diseases. The NDA is supported by data from ESLIM-01, a randomized, double-blinded, placebo-controlled Phase III trial in China of sovleplenib in 188 adult patients with primary ITP who have received at least one prior line of standard therapy. In August 2023, HUTCHMED announced that the trial had met its primary endpoint of demonstrating a clinically meaningful and a statistically significant increase in durable response rate in patients treated with sovleplenib as compared to patients treated with placebo. Secondary endpoints including response rate and safety were also met. Full results will be published in due course. Results from the proof of concept study that led to the ESLIM-01 study were published in The Lancet Haematology.

17:56 EST Grayscale gets SEC approval for Grayscale Bitcoin Trust to list as spot ETF - Grayscale Investments, the world's largest crypto asset manager announced that the U.S. Securities and Exchange Commission or SEC has approved NYSE Arca's application pursuant to Rule 19b-4 under the Securities Exchange Act of 1934 to list the shares of its flagship product, Grayscale Bitcoin Trust (GBTC) and is expected to declare GBTC's registration statement on Form S-3 effective as of 5:00 p.m. EST . The approval of the application and effectiveness of the registration statement will allow GBTC to operate as a spot Bitcoin ETF and will make it among the first such products to be brought to market in the U.S. GBTC shares will be listed on NYSE Arca under the Ticker: GBTC. Shares of GBTC are expected to commence trading on NYSE Arca on January 11 . Once GBTC shares start trading on NYSE Arca, GBTC shares will cease trading on the OTC Markets and will have automatically been uplisted to NYSE Arca as shares of a spot Bitcoin ETF. Current GBTC shareholders do not have to take any action prior to GBTC's expected uplisting to NYSE Arca...Once the shares are listed on NYSE Arca, the Trust intends to issue additional shares on a registered basis under the Securities Act of 1933. Other symbols and stocks in the cryptocurrency space include: lude Riot Blockchain (RIOT), Marathon Digital (MARA), Coinbase (COIN) and MicroStrategy (MSTR).

17:43 EST General Dynamics awarded $438.52M Navy contract modification - General Dynamics was awarded a not-to-exceed $438.52M cost-plus-fixed-fee modification to a previously awarded undefinitized contract action for the maintenance, modernization, and repair of USS Chung-Hoon and USS James E. Williams fiscal 2024 Depot Maintenance Period availabilities. The scope of this acquisition includes all labor, materials, supervision, equipment, production, testing, facilities, and quality assurance necessary to prepare for and accomplish the Chief of Naval Operations Availabilities for critical modernization, maintenance and repair programs. This contract includes options, which, if exercised, would bring the cumulative value of this contract to $864.14M. If all options are exercised, work will continue through November 2030. Naval Sea Systems is the contracting activity.

17:32 EST Steel Partners abandons reverse/forward unit split - Steel Partners will abandon its 1-for-12,500 reverse unit split of its common units, no par value, followed immediately by a 12,500-for-1 forward unit split of the company common units. The Reverse/Forward Unit Split was previously extended on January 8 and was expected to become effective on January 11.

17:17 EST Zai Lab announces NEJM published data from TRIDENT-1 study - Zai Lab announced The New England Journal of Medicine, or NEJM, has published data from the registrational Phase 1/2 TRIDENT-1 study evaluating repotrectinib in patients with ROS1 fusion-positive non-small cell lung cancers, or NSCLCs. Repotrectinib is a tyrosine kinase inhibitor, or TKI, that has shown robust anti-tumor activity against ROS1+ cancers in preclinical models. In the TRIDENT-1 study, repotrectinib demonstrated high response rates and durable activity in patients with ROS1+ NSCLC, including patients with TKI-naive and TKI-pretreated tumors, ROS1 G2032R resistance mutations and brain metastases. Treatment with repotrectinib was generally well tolerated with a manageable safety profile compatible with long-term administration. Turning Point Therapeutics, a wholly owned subsidiary of the Bristol-Myers Squibb Company, sponsored and designed the global, registrational TRIDENT-1 study. In August 2022, Bristol Myers Squibb acquired the company, including its asset repotrectinib. As part of its exclusive license agreement with Turning Point Therapeutics to develop and commercialize repotrectinib in Greater China, Zai Lab participated and enrolled 81 patients for this trial. Every year in China, more than 800,000 people are newly diagnosed with lung cancer, and NSCLC accounts for approximately 85% of the cases. ROS1 rearrangements occur in less than or equal to2% of patients with NSCLC1. Brain metastases are common among patients with ROS1+ NSCLC and intracranial activity of approved ROS1 TKIs can be suboptimal.

17:01 EST Alamos Gold reports Q4 total gold production 129,500 ounces - Alamos Gold Inc. reported fourth quarter and annual 2023 production. The Company also provided updated three-year production and operating guidance. "We finished 2023 with another strong quarter, achieving the top end of our increased annual guidance with record production of 529,300 ounces of gold. This represented a 15% increase from 2022, at lower costs, driving a record financial performance and strong free cash flow, all while continuing to invest in high-return, low-cost growth," said John A. McCluskey, President and Chief Executive Officer. "We expect this strong performance to continue with growing production and declining costs over the next several years. Mulatos continues to outperform, supporting an increase in our 2024 production guidance. The Phase 3+ Expansion at Island Gold remains on track to deliver further production growth, decreasing costs, and substantial free cash flow growth into 2026 and beyond. We are advancing our other growth initiatives with the development plan for PDA expected to be completed later this quarter, outlining additional production upside as early as 2026, and with Lynn Lake to provide further low-cost production growth as early as 2027. We have also increased our exploration budget to the highest level in our history reflecting the ongoing success and significant upside we see across our asset base," Mr. McCluskey added.

16:36 EST SEC approves listing and trading of spot bitcoin exchange-traded products - SEC Chair Gary Gensler issued the following statement on the approval of spot bitcoin exchange-traded products: "Today, the Commission approved the listing and trading of a number of spot bitcoin exchange-traded product (ETP) shares. I have often said that the Commission acts within the law and how the courts interpret the law. Beginning under Chair Jay Clayton in 2018 and through March 2023, the Commission disapproved more than 20 exchange rule filings for spot bitcoin ETPs. One of those filings, made by Grayscale, contemplated the conversion of the Grayscale Bitcoin Trust into an ETP. We are now faced with a new set of filings similar to those we have disapproved in the past. Circumstances, however, have changed. The U.S. Court of Appeals for the District of Columbia held that the Commission failed to adequately explain its reasoning in disapproving the listing and trading of Grayscale's proposed ETP (the Grayscale Order). The court therefore vacated the Grayscale Order and remanded the matter to the Commission. Based on these circumstances and those discussed more fully in the approval order, I feel the most sustainable path forward is to approve the listing and trading of these spot bitcoin ETP shares... Importantly, today's Commission action is cabined to ETPs holding one non-security commodity, bitcoin. It should in no way signal the Commission's willingness to approve listing standards for crypto asset securities. Nor does the approval signal anything about the Commission's views as to the status of other crypto assets under the federal securities laws or about the current state of non-compliance of certain crypto asset market participants with the federal securities laws. As I've said in the past, and without prejudging any one crypto asset, the vast majority of crypto assets are investment contracts and thus subject to the federal securities laws... Though we're merit neutral, I'd note that the underlying assets in the metals ETPs have consumer and industrial uses, while in contrast bitcoin is primarily a speculative, volatile asset that's also used for illicit activity including ransomware, money laundering, sanction evasion, and terrorist financing. While we approved the listing and trading of certain spot bitcoin ETP shares today, we did not approve or endorse bitcoin. Investors should remain cautious about the myriad risks associated with bitcoin and products whose value is tied to crypto." Publicly traded companies in the space include Bit Digital (BTBT), Coinbase (COIN), Core Scientific (CORZ), Greenidge Generation (GREE), Marathon Digital (MARA), MicroStrategy (MSTR), Riot Platforms (RIOT), Stronghold Digital Mining (SDIG) and TeraWulf (WULF). Reference Link

16:34 EST Hecla Mining reports 2023 silver production 14.3M ounces - Silver production of 14.3 million ounces exceeded 2022 production of 14.2 million ounces, despite the temporary shutdown at the Lucky Friday mine since August 2023. As expected, annual gold production decreased 14% as Casa Berardi transitions to an open pit mine; Greens Creek gold production increased 26%. Commenced restart at the Lucky Friday; ramp-up to full production and receipt of insurance payments expected to commence in the first quarter of 2024. Keno Hill produced 1.5 million ounces, with the Bermingham deposit achieving the highest mined tonnage in December; initiated a safety action plan to build a strong operational foundation at the mine. "Hecla faced multiple challenges in 2023 with the fire at the Lucky Friday mine and improving the safety culture at Keno Hill, but despite these challenges, silver production exceeded last year as Greens Creek delivered another strong year, Lucky Friday's production through July with our patented UCB method produced more silver than the mine typically produced in a full year with the old mining method, and the roughly half year of production at Keno Hill shows its potential to be a meaningful producer," said Phillips S. Baker, Jr., Hecla's President and CEO. "As planned, we began the transition of Casa Berardi's production to surface mining, which lowered production but increased margins."

16:32 EST Informa to combine Informa Tech's digital units with TechTarget - TechTarget (TTGT) and Informa (IFPJF) announced that the companies have entered into a definitive agreement whereby Informa PLC will combine Informa Tech's digital businesses with TechTarget to create a leading global platform in B2B Data and Market Access, focused on helping vendors in enterprise technology and other markets accelerate revenue growth. The combined company ("New TechTarget") is expected to position TechTarget as a unique end-to-end solution provider across the go-to-market: from strategy, messaging and content development to in-market activation via brand, demand generation, purchase intent data and sales enablement. The combination brings scale benefits, diversified revenue streams and strategic expansion opportunities by expanding TechTarget's current addressable market and enhancing the resilience of its business by increasing its presence in new markets and new buyer personas. Informa PLC will contribute its Informa Tech digital businesses and $350 million of cash in exchange for a 57% stake in the combined company. The $350 million of cash, or approximately $11.79 per outstanding TechTarget share, will be paid to existing TechTarget shareholders upon completion of the transaction. Existing TechTarget shareholders will also retain a 43% equity stake in New TechTarget, allowing them to participate in the long-term value creation of the combined company. "The addition of Informa Tech's digital businesses has the ability to accelerate TechTarget's strategic roadmap by allowing it to continue to innovate leading products, offer customers end-to-end solutions and grow profitably and create a platform to complete meaningful strategic acquisitions," said Gregory Strakosch, Executive Chairman and Co-Founder of TechTarget. "Following a robust evaluation by the Board of Directors of strategic alternatives focused on enhancing shareholder value, the Board unanimously believes the proposed transaction is highly attractive to our shareholders, providing immediate cash value as well as the opportunity to continue to participate in the long-term value-creation of a larger, more diversified and stronger combined company."

16:30 EST SAP pays over $220M to resolve Foreign Corrupt Practices Act probe - SAP will pay over $220M to resolve investigations by the U.S. Justice Department and the Securities and Exchange Commission into violations of the Foreign Corrupt Practices Act, the Justice Department announced. SAP's resolution with the department "stems from schemes to pay bribes to government officials in South Africa and Indonesia. The department's resolution is coordinated with prosecutorial authorities in South Africa, as well as with the SEC," the agency said in a statement. According to court documents, SAP entered into a three-year deferred prosecution agreement with the department in connection with a criminal information filed in the Eastern District of Virginia charging the company with two counts: conspiracy to violate the anti-bribery and books and records provisions of the FCPA relating to its scheme to pay bribes to South African officials, and conspiracy to violate the anti-bribery provision of the FCPA for its scheme to pay bribes to Indonesian officials. Reference Link

16:29 EST Victory Capital reports AUM of $166.6B as of December 31, 2023 - Victory Capital Holdings reported assets under management of $166.6B as of December 31, 2023, and average assets under management for December of $163.5B. The company also reported long-term net flows in the fourth quarter of -$1.1B.

16:25 EST Rocky Mountain Chocolate targets return to profitability in FY25 - Sarlls continued, "As we close fiscal 2024, the actions we have taken over the past year have laid the groundwork for the future of the Company, and we believe we are approaching an inflection point that will enable Rocky Mountain Chocolate to return to growth and profitability in fiscal 2025."

16:23 EST Artisan Partners reports December AUM $150.2B - Artisan Partners Asset Management reported that its preliminary assets under management as of December 31, 2023 totaled $150.2 billion. Artisan Funds and Artisan Global Funds accounted for $72.8 billion of total firm AUM, while separate accounts and other AUM1 accounted for $77.4 billion. In December, certain Artisan Funds made their annual income and capital gains distributions. December month-end AUM includes the impact of approximately $115 million of Artisan Funds distributions not reinvested.

16:17 EST Invesco reports preliminary AUM $1.59T as of December 31, 2023 - Invesco reported preliminary month-end assets under management of $1.59T, an increase of 2.8% versus previous month-end. The firm delivered net long-term inflows of $5.1B in the month. Non-management fee earning net outflows were $1.3B and money market net outflows were $13B.

16:15 EST Yum! Brands names Joe Park chief digital & technology officer - Yum! Brands announced the promotion of Joe Park to Chief Digital & Technology Officer, reporting to Chris Turner, Yum! Brands Chief Financial Officer, effective March 1, 2024. Park, who most recently served as Chief Digital & Technology Officer for Pizza Hut Global, succeeds Clay Johnson, who will continue with Yum! Brands as a Senior Advisor. As CDTO, Park will join the Yum! Brands Global Leadership Team and oversee the Company's global technology strategy, partnering with the KFC, Pizza Hut, Taco Bell and the Habit Burger Grill divisions to ensure the Company provides a best-in-class digital experience for customers and restaurant team members and strong economics for franchisees. "We're ingraining digital and technology into all aspects of our business with exciting new capabilities that make things easy for customers and restaurant team members, while driving profitable growth for Yum! and our franchisees," said Turner. "We've made great progress enhancing digital ordering, implementing technologies to improve restaurant operations, leveraging data to enable smart decision-making and piloting emerging technologies, and Joe Park has been an exceptional partner on this journey over the past few years. Joe is an energizing and visionary leader with a proven track record of rapidly deploying modern eCommerce and data platforms and scaling innovative technologies like Dragontail and HutBot across Pizza Hut's global system. I'm confident that Joe will help Yum! continue to strengthen our technology ecosystem and scale our digital solutions at a rapid pace to deliver leading-edge capabilities to our franchisees with advantaged economics."

16:11 EST Elutia regains compliance with Nasdaq listing requirements - Elutia announced that it has regained compliance with Nasdaq's market value of listed securities requirement and majority independent board requirement. As a result, the Company now satisfies all applicable requirements for continued listing with Nasdaq, and the Company's Class A common stock will continue to be listed and traded on the Nasdaq Capital Market under the symbol "ELUT." "We are pleased to have received confirmation from Nasdaq of our compliance with their listing requirements," said Kevin Rakin, Chairman of Elutia. "With the divestiture of our orthopedics business and successful capital raise, 2023 was a transformative year for Elutia. Randy Mills, our CEO, and the leadership team are now fully focused on the commercial launch of our pioneering drug-eluting biomatrix, CanGarooRM(R), and we look forward to a favorable FDA decision in the first half of this year."

16:10 EST Safe Bulkers to buy Japanese Kamsarmax class dry-bulk vessel, no terms - Safe Bulkers announced that it has entered into an agreement for the acquisition of a Japanese, 82,000 dwt, dry-bulk, Kamsarmax class vessel with a scheduled delivery date within the third quarter of 2026. The newbuild vessel is designed to meet the Phase 3 requirements of Energy Efficiency Design Index related to the reduction of greenhouse gas emissions as adopted by the International Maritime Organization, and also comply with the latest NOx emissions regulation, NOx-Tier III . T "Consistent with our ESG strategy, we have placed an additional order for a Phase 3 newbuild targeting a gradual fleet renewal and the subsequent operational and financial advantages associated with it."

16:07 EST ChargePoint announces reorganization, to cut about 12% of global workforce - ChargePoint announced a strategic reorganization designed to improve financial performance and position itself for long-term, sustainable growth. The reorganization includes an approximately 12% reduction of the ChargePoint global workforce. The reorganization is expected to lead to approximately $14 million in restructuring charges, consisting of approximately $10 million in severance and related expenses and approximately $4 million in facility-related expenses. ChargePoint expects the action to result in annual operating expense savings of approximately $33 million. As previously announced, additional components of the strategic plan under new President and Chief Executive Officer, Rick Wilmer, will be discussed in ChargePoint's fourth quarter of fiscal 2024 investor call expected to be held in March of this year. "As part of a comprehensive business evaluation in my new position as CEO, today we have taken the difficult decision to reorganize our global workforce," said Rick Wilmer, President and CEO of ChargePoint. "After a thorough review of our business strategy and product roadmap, we are heightening our focus on execution, operational excellence, and improved efficiencies while we continue with our industry-leading innovation." As previously announced, ChargePoint maintains a strong financial position with approximately $397 million in cash, cash equivalents and restricted cash on the Company's balance sheet at the end of the third quarter of fiscal year 2024, with access to an additional $150 million through a revolving credit facility, which remains undrawn. The Company remains committed to its plan for achieving positive non-GAAP adjusted EBITDA in the fourth quarter of calendar year 2024.

16:05 EST AllianceBernstein reports preliminary AUM $725B as of December 31, 2023 - Up from $696B at the end of November. The 4% AUM increase was driven by market appreciation with slight firmwide net outflows. By channel, December net flows were flat within Institutions and Retail, while Private Wealth posted minimal net outflows.

16:05 EST Werner names Nathan Meisgeier president - Werner Enterprises announced that, upon the recommendation of its Chairman and Chief Executive Officer, Derek J. Leathers, the Company's Board of Directors unanimously appointed Nathan J. Meisgeier to serve as Werner's President, effective January 5, 2024. Mr. Meisgeier will continue to hold the position of Werner's Chief Legal Officer. Leathers will remain the Company's Chairman and CEO. "Since being promoted to Werner's General Counsel in 2016, Nathan has been a transformative leader across the enterprise, currently acting as Chief of Staff and bringing a remarkable level of integrity and strategic vision to our company. Nathan is a company-first servant leader, naturally connecting with all Werner associates - professional drivers, maintenance associates, and office personnel. Nathan exemplifies the culture that makes Werner a great place to work," said Mr. Leathers.

16:05 EST Avita Medical in distribution pact with Stedical Scientific for PermeaDerm - AVITA Medical announced it has entered into an exclusive multi-year distribution agreement with Stedical Scientific, to commercialize PermeaDerm Biosynthetic Wound Matrix in the United States. PermeaDerm is cleared by the Food and Drug Administration as a transparent matrix for use in the treatment of a variety of wound types until healing is achieved. Under the terms of the agreement, AVITA Medical will hold the exclusive rights to market, sell, and distribute PermeaDerm products, including any future enhancements or modifications, within the United States. The initial term is for five years, with the option to renew for an additional five years, contingent upon meeting certain minimums. The Company expects the gross margin from the sale of PermeaDerm to be 50% of the average sales price. "Our partnership with Stedical Scientific is an important step in expanding our portfolio and addressing the unmet needs of our patients," said Jim Corbett, Chief Executive Officer of AVITA Medical. "AVITA Medical and Stedical Scientific are ideal partners given the complementary nature of our products, the overlap of call points, and the strength of our footprint and sales force. We anticipate these synergies will allow us to effectively leverage our established commercial presence, enhancing the integration of PermeaDerm into our portfolio. This strategic collaboration underscores our commitment to delivering innovative solutions and improving outcomes for those we serve."

16:02 EST Leonardo DRS awarded contracts valued over $3B for U.S. Navy's submarine program - Leonardo DRS (DRS) has been awarded contracts valued at over $3B, when fully funded, to provide integrated electric propulsion system products for the U.S. Navy's Columbia-class submarines. This contract solidifies DRS's position through shipset 12 for the Columbia-class program. This award was previously announced on the DRS 2023 Q3 earnings call. Leonardo DRS was chosen by General Dynamics Electric Boat (GD) and the U.S. Navy to design and manufacture the permanent magnet main propulsion electric motor, the propulsion motor drives, switchgear, and the propulsion controls - the heart of the Columbia Electric Drive Propulsion System. These are key components of the primary propulsion system of the next-generation ballistic missile submarine fleet. All prototype components of this system successfully completed full power endurance and other testing at the Navy's land-based test facility. "This award highlights Leonardo DRS as an agile and trusted partner for the U.S. Navy and General Dynamics Electric Boat, having now been awarded contracts to supply our state-of-the-art electric propulsion components through shipset 12 for the Columbia-class program," said Leonardo DRS CEO Bill Lynn. "We are proud to be a part of this team and be the provider of these critical components for the most advanced ballistic missile submarine in our Navy's history."

15:02 EST BeyondSpring reports Nasdaq delinquency notice for late filing - BeyondSpring announced that on January 4, it received a Foreign Delinquency Compliance Plan Alert Letter from The Nasdaq Stock Market because it has not timely filed its Form 6-K for the period ended June 30, 2023. "In accordance with Nasdaq Listing Rules, the Company has 60 calendar days to submit a plan to regain compliance. If Nasdaq accepts the Company's plan, Nasdaq can grant the Company an exception of up to 180 calendar days from the Filing's due date, or until July 1, 2024, to regain compliance. The Letter has no immediate effect on the listing or trading of the Company's ordinary shares on Nasdaq. The Company's management is working diligently to complete the Filing as soon as practicably possible to regain compliance with the Nasdaq Listing Rule 5250(c)(2)," the company stated.

14:37 EST Viatris CEO sees 'minimum' free cash flow in $2.3B range over next 3 to 5 years - Asked during the JPMorgan Healthcare Conference about what Viatris is most focused on for 2024 and over the next few years, CEO Scott Andrew Smith replied, according to a transcript of the event: "So I wouldn't say that we have the divestitures behind us. They're announced, we need to work through that and close them and they'll continue to close as we get through sort of the end of the first half this year. Once we get those divestitures, we'll be focusing on paying down our debt to get to that target ratio. And after that, we're going to execute our strategic plan, right, and our capital allocation plan. Approximately over the next 3 to 5 years, 50% of that free cash flow, which at a minimum should be at the $2.3 billion range, 50% return to shareholders through share buybacks which we're going to try and be increasingly aggressive around as we move in '24 and '25, the dividend, of course, and then for business development. And as I mentioned, I see business development as far more than just binary M&A I think licensing, partnering, strategic arrangements, research agreements and things like that are very, very important to our future. So I see a fulsome approach to business development and building the portfolio long term. And I think for me, the base of the company is so strong. We've integrated. We've streamlined. We're now moving, and we've seen in the last couple of quarters real organic revenue growth. And that solid base of the business allows us to do the other things, but we're going to execute our capital allocation plan as laid out, and we're going to build the company and the future revenue streams of the company through business development."

14:14 EST Viatris up 5% amid healthcare conference presentation - Shares of Viatris are up 5% to $12.22 in afternoon trading. The company was scheduled to begin a presentation at the JPMorgan Healthcare Conference at 1:30 pm ET.

13:54 EST Pono Capital Three Inc trading halted, volatility trading pause

13:13 EST PagerDuty up 14% after Bloomberg report on private equity interest

12:03 EST LeddarTech, Black Sesame collaborate for ADAS solutions - Black Sesame Technologies and LeddarTech announced their partnership to jointly develop and market a comprehensive portfolio of automotive hardware and software technology for the Chinese domestic and global OEM / Tier 1 ADAS/AD market. Black Sesame Technologies and LeddarTech are collaborating to provide a joint solution offering for the surround-view premium L2/L2+ ADAS/AD market segment, leveraging Black Sesame Technologies' A1000 SoC and LeddarTech's LeddarVision LVS-2+ surround-view premium highway assist and 5-star NCAP/GSR 2022 AI-based low-level fusion and perception stack.

12:00 EST E2open rises 6.9% - E2open is up 6.9%, or 27c to $4.11.

12:00 EST Saratoga Investment falls -7.2% - Saratoga Investment is down -7.2%, or -$1.86 to $24.04.

12:00 EST Ouster falls -9.3% - Ouster is down -9.3%, or -69c to $6.71.

11:17 EST Spirit AeroSystems says team supporting NTSB investigation - Spirit AeroSystems (SPR) said it "has been working closely with our customer since the event with Alaska Airlines Flight 1282 on Jan. 5." The company added, "A Spirit team is now supporting the NTSB's investigation directly. As a company, we remain focused on the quality of each aircraft structure that leaves our facilities."

11:01 EST Instructure names Rachel Orston CCO - Instructure announced Rachel Orston as its new Chief Customer Officer. Instructure's CX team leverages real-world educational experience as it helps customers improve student outcomes, with over half of its CX team having taught or worked in educational institutions. Former Chief Customer Experience Officer Melissa Loble now assumes the newly-created Chief Academic Officer role full-time to further elevate the educator experience and surround customers with academic expertise. "Instructure's unique approach of surrounding customers with passionate, experienced advocates attracted me to this role," said Orston. "I look forward to building on a legacy of outstanding customer experience and making learning more accessible as we work alongside educators."

10:15 EST Sony Music Masterworks launches JV with Roast Productions - Sony Music Masterworks announced a new strategic venture with Roast Productions, a live entertainment company founded by Bonnie Royal and Michael Stevens. Based in London and operating internationally, Roast Productions focuses on producing theatre, concerts, and family entertainment events. Royal and Stevens will continue to lead the company's day-to-day operations and collaborate with Masterworks on the development of a range of new productions, working in close partnership with both Masterworks President Mark Cavell and Ollie Rosenblatt, founder and CEO of Senbla, a UK producer/promoter. Recent and current shows include MACBETH starring Ralph Fiennes and Indira Varma playing in Liverpool, Edinburgh, London and Washington DC; 2:22 A GHOST STORY in the West End touring in the UK and Australia; CHRISTMAS ACTUALLY, a Christmas variety show curated by "Love Actually" filmmaker Richard Curtis and produced in partnership with Senbla; the highly acclaimed West End run of VANYA starring Andrew Scott; and the new musical COWBOY BOB at the Alley Theatre in Houston, TX; as well as the 2024 UK tour of THE 13-STOREY TREEHOUSE based on the best-selling book by Andy Griffiths and Terry Denton. The company will also offer production, general management, and marketing services in the West End and beyond. At the same time, Roast Productions is pleased to announce strategic agreements with National Theatre Productions and Various Productions, as co-producer for STANDING AT THE SKY'S EDGE at the Gillian Lynne Theatre opening in February, and with the Ambassador Theatre Group, as Creative Producer of the inaugural WIMBLEDON CHILDREN'S FESTIVAL at the New Wimbledon Theatre, launching in Summer 2024.

10:01 EST Sana Biotechnology trading resumes

10:00 EST Sasol falls -6.8% - Sasol is down -6.8%, or -66c to $9.08.

10:00 EST Vince Holding rises 7.1% - Vince Holding is up 7.1%, or 30c to $4.50.

10:00 EST E2open rises 13.0% - E2open is up 13.0%, or 50c to $4.34.

09:47 EST Vince Holding rises 6.4% - Vince Holding is up 6.4%, or 27c to $4.47.

09:47 EST E2open rises 19.0% - E2open is up 19.0%, or 73c to $4.57.

09:47 EST Saratoga Investment falls -5.5% - Saratoga Investment is down -5.5%, or -$1.44 to $24.46.

09:45 EST Jin Medical International Ltd trading resumes

09:42 EST Neximmune Inc trading resumes

09:40 EST Jin Medical International Ltd trading halted, volatility trading pause

09:37 EST Neximmune Inc trading halted, volatility trading pause

09:31 EST Bit Brother Ltd trading halted, volatility trading pause

09:14 EST FingerMotion launches lifestyle consumer app - FingerMotion announces its subsidiary, Shanghai JuiGe Information Technology Co., Ltd., has launched a new consumer application called "Da Ge" introducing subscribers to services such as car washing, detailing and maintenance, linking automobile owners with full service independent service stations. Da Ge has already onboarded 18,000 car care service stations and anticipates over 25,000 service stations by the end of 2024. The national rollout had generated a post-beta engagement of 200,000 active subscribers and anticipates 2,000,000 subscribers by the end of 2024, targeting the first and second tier cities throughout China. The current services available to subscribers include car detailing and maintenance, with future product offerings to possibly incorporate our current top up business, car accessories, and potentially health and auto insurance. We anticipate the Da Ge business segment to rapidly run cash flow positive and to be reflected in the financials of Q4 2024.

09:11 EST DISH Wireless awarded $50M NTIA grant from NTIA - DISH Wireless, a subsidiary of EchoStar, was awarded a historic $50M grant from the U.S. Department of Commerce's National Telecommunications and Information Administration to establish the Open RAN Center for Integration & Deployment. ORCID will allow participants to test and validate their hardware and software solutions against a complete commercial-grade Open RAN network deployed by DISH.

09:09 EST Dow Jones launches Factiva Sentiment Signals powered by Oliver Wyman - Dow Jones has partnered with Oliver Wyman to launch Factiva Sentiment Signals, a corporate risk solution that deploys news-derived data to predict entity risk events up to three months in advance. Harnessing state-of-the art AI and natural language processing developed by Oliver Wyman, the unique, predictive solution is able to analyze thousands of global news sources in Factiva to identify indicators of emerging risks such as financial distress, operational disruption as well as liquidity and fraud concerns. These signals surface in news media up to three months before major risk events, serving as a transparent and accurate early-warning system for corporate credit risk. The resulting sentiment signal enables organizations to monitor, anticipate and mitigate against unprecedented credit events before they disrupt business operations and create adverse financial impact.

09:07 EST TeleVox expands overseas to support United States Military - TeleVox to announces the expansion of its solutions to support the United States military overseas. Now available in facilities in 13 areas outside the continental U.S., TeleVox offers timely and reliable SMS, email, and voice services to help ease the burden of booking medical appointments and accessing referrals for military members stationed abroad. As a core Leidos Partnership for Defense Health partner, Oracle Health is helping to deploy a single, common electronic health record named Military Health System GENESIS and contracted with TeleVox to provide its notification services as part of the overall project. TeleVox is part of West Technology Group, LLC, controlled by affiliates of certain funds managed by Apollo Global Management

09:06 EST Stagwell partners with MNTN - Stagwell is partnering with connected TV advertising leader MNTN to broaden the market of performance advertising for brands. With the partnership, brands will now have access to a comprehensive set of buying solutions that combine the best of MNTN's Performance TV platform with Stagwell Marketing Cloud products, providing added streaming, performance PR and performance influencer capabilities in a one-stop shop. Brands can now attach metrics to their big marketing ideas in a granular way.Stagwell and MNTN's strategic partnership allows for a more unified approach to brand and performance media, offering brands access to advanced technologies and a comprehensive suite of tools enabling brand campaigns on television to now seamlessly coexist with other digital channels.

09:05 EST Synchrony, The Good Feet Store extend financing partnership - Synchrony announced a multi-year partnership renewal with The Good Feet Store, a manufacturer and retailer of premium, personally fitted arch supports. Under the expanded agreement, Synchrony's CareCredit health and wellness credit card will be offered as an in-store payment option at most of The Good Feet Store's more than 250 brick-and-mortar locations, enabling customers to finance arch support products for improved alignment and less pain.

09:05 EST 3D Systems appoints Puthenveetil as EVP, Additive Solutions, CCDO - 3D Systems announced changes in the company's leadership structure. Reji Puthenveetil, who currently serves as EVP, Industrial Solutions, will take on expanded responsibilities as EVP, Additive Solutions and Chief Commercial Officer. In addition, after a productive 17-year career with the company, Andy Johnson, Chief Corporate Development Officer, CCDO, and Chief Legal Counsel. CLO, will be leaving 3D Systems to pursue new leadership opportunities.

09:04 EST Sinclair and Verizon reach multi-year distribution agreement, no terms - Sinclair (SBGI) announced the company has reached a comprehensive multi-year distribution agreement with Verizon (VZ) for carriage on FiOS TV. The agreement covers local television stations in 10 markets, Tennis Channel and YES Network. Commenting on the agreement, Will Bell, Sinclair's SVP and Head of Distribution and Network Relations stated, "We are pleased to have reached a renewal agreement with Verizon without any disruption in service to viewers, keeping our best-in class news, sports and entertainment content available on the platform for years to come." Financial terms of the deal were not disclosed.

09:03 EST DDC Enterprise enters agreement to acquire 51% of G.L. Industry - DDC Enterprise announces it has entered into an agreement to acquire 51% of G.L. Industry. The acquisition will continue the expansion of DayDayCook's international footprint and will be financed through a combination of cash and DDC stock. Oaklins HFG China provided advisory services for this transaction. Cristian Lin, Founder and CEO of GLI added, "I believe the union between DayDayCook and GLI provides a unique opportunity for growth, as the business of ready-Asian meals in Europe is rapidly developing. The DayDayCook brand is one we are proud to become a part of."

09:02 EST 3M awarded $34.2M from U.S. Army Medical Research Acquisition Activity - 3M Health Care's Medical Solutions Division was awarded $34.2M from the U.S. Army Medical Research Acquisition Activity to develop a range of new solutions for infection prevention, wound management and wound healing. 3M will lead a program focused on treatment strategies that can be used in austere settings, especially those related to mass casualty and delayed evacuation situations. In addition, the program will work to assess biofilm control, biomarker monitoring and healing in acute trauma situations such as blasts, burns, and gunshot wounds that occur in civilian and military settings. 3M will collaborate with the University of Minnesota Medical School, the 59th Medical Wing Science & Technology Office of the Chief Scientist, Naval Medical Research Unit-San Antonio and The University of Texas Health Science Center at San Antonio in this program. The awarded funding will support four separate product solutions, with studies that range from prototype and formulation development to completion of two clinical studies to be used for product registration.

08:56 EST EVgo and Toyota team for 1 year complimentary fast charging to 2024 bZ4X clients - EVgo (EVGO) announced an extension of its agreement with Toyota Motor North America, Toyota (TM) to provide drivers who purchase or lease a new 2024 bZ4x with one year of complimentary fast charging on EVgo's nationwide network."Our collaboration with Toyota gives even more EV drivers access to our industry-leading charging network and the ability to plug in across the U.S." First announced in February 2022, the ongoing collaboration between EVgo and Toyota to offer complimentary charging helps boost range confidence for EV drivers by unlocking access to EVgo's owned and operated public fast charging network with stations from coast to coast. "The expansion of our agreement is a testament to the convenience and accessibility of the EVgo network, as well as to our ongoing commitment to automaker collaborations that help spur the mass adoption of EVs throughout the country," said Maggie Tallman, Senior Vice President, Business Development at EVgo. "Our collaboration with Toyota gives even more EV drivers access to our industry-leading charging network and the ability to plug in across the U.S."

08:54 EST Mynaric reports optical communications terminal backlog of 794 units - Mynaric reported on key performance indicators for the year ending December 31, 2023. As of December 31, 2023, the optical communications terminal backlog and cash-in from customer contracts is as follows: Optical communications terminal backlog: 794 units; Cash-in from customer contracts: EUR 49.2 million; IFRS-15 revenue and operating loss: Based on preliminary, unaudited numbers the company expects revenue and operating loss in-line with the previously communicated range. The vast majority of the optical communications terminals in backlog as of December 31, 2023 includes deliverables with key aerospace and defense customers that are related to government-funded satellite constellations with the bulk deliveries scheduled to start in the first quarter of 2024 and continue into 2025 and 2026, which provides Mynaric with excellent revenue and cash flow visibility on these programs.

08:49 EST PodcastOne launches Varnamtown podcast - PodcastOne announced the January 24, 2024 premiere of Varnamtown, a limited 8 episode true crime genre podcast from Epic Magazine, Picture Perfect Federation and Full Picture. Hosted by Golden Globe Award winning actor Kyle MacLachlan and investigative journalist Joshua Davis, Varnamtown tells the little known story of a small fishing village in North Carolina that reputedly did a deal with drug kingpin Pablo Escobar. In exchange for allowing Escobar's drug motherships to dock and his airplanes to land, the town would become rich. For two years, MacLachlan and Davis investigated the tale, journeying to Varnamtown to knock on doors and find out what really happens when a firehose of money and cocaine is turned on a small, tight knit community.

08:42 EST Navitas Semiconductor appoints Janet Chou as CFO - Navitas Semiconductor (NVTS) announced the appointment of Janet Chou as EVP, CFO and Treasurer, effective upon the filing of Navitas' 2023 annual report on Form 10-K expected at the end of February. Chou will report to Gene Sheridan, President and CEO, and will replace Ron Shelton, Senior Vice President, CFO and Treasurer, who announced his intention to pursue other opportunities effective March 15, 2024. Following the Form 10-K filing, Shelton will provide advice and assistance to Sheridan and transition assistance and support to Chou. Chou was previously Vice President and CFO of Global Operations for Western Digital Corporation (WDC).

08:41 EST Avikus, Aquasport Boats enter autonomous AI technology partnership - Twin Vee PowerCats (VEEE) and Avikus revealed a partnership that is set to redefine the landscape of recreational sport boating. Avikus and Twin Vee's subsidiary, AquaSport Boats, announced a partnership intended to create the world's first autonomously equipped recreational sport boat company. Avikus and AquaSport Boats are embarking on an exhilarating journey to revolutionize the recreational boating experience. The fusion of Avikus' autonomous prowess with AquaSport's industry vision and market expertise is expected to pave the way for an entirely new era in aquatic adventures. The Company plans to deliver a line of center and dual console recreational sport boats, each craft meticulously designed, developed, and manufactured to provide an unparalleled boating experience that incorporates advanced navigation assistance and autonomous functionality. The first models are scheduled to make their debut this summer, with additional models being introduced in late 2024 under the Twin Vee, Forza X1 (FRZA), and AquaSport brands.

08:37 EST Signing Day Sports achieved record results during 2023 U.S. Army Bowl week - Signing Day Sport announced that the Company achieved record results at the recently completed 2023 U.S. Army Bowl Week in Frisco, Texas. Danny Nelson, Chief Executive Officer of Signing Day Sports, stated, "The success of the 2023 U.S. Army Bowl Week has invigorated the Signing Day Sports team. Witnessing the increased attendance and the positive social media buzz has been phenomenal. We were especially encouraged by the unexpected but welcomed engagement from parents seeking additional guidance from Signing Day Sports beyond football, expressing their interest in mental health, nutrition, and other issues, reflecting the impact and resonance that our platform is having with parents and student-athletes alike. We are excited about the possibilities ahead and plan to turn this valuable feedback into actionable initiatives to further enhance the platform. This may include the addition of a new apparel line, nutritional supplements, or other similar items. We look forward to continuing our association with the U.S. Army Bowl Week in future years."

08:35 EST Foremost Lithium receives multi-year work permit for Jean Lake Project - Foremost Lithium Resource & Technology confirms that it received a multi-year work permit for its Jean Lake Lithium/Gold Project from the Mining Permit Office of the Manitoba Government, valid until April 30th of 2026. This permit will enable the Company to streamline the administrative processes involved with future exploration on the property, to understand the potential long-term impacts of the property while minimizing any potential work disruptions in a safer, more cost-effective approach. Foremost Lithium's CEO and President, Jason Barnard, states: "Crews have begun mobilizing to Snow Lake, Manitoba in preparation for the winter drill season. The multi-year permit allows our company the flexibility to optimize our future work on the property, which is critical as we seek to rapidly advance our resource development. This is paramount to unlocking the potential of the Jean Lake property and creating sustainable, long-term shareholder value."

08:33 EST ASP Isotopes provides corporate update - ASP Isotopes provided a corporate update regarding the Company's operations in Pretoria, South Africa. During December 2023, the Company and its North American commercial partner, RC14 Inc., started processing the raw materials for the production of highly enriched carbon-14, at the Company's light isotope enrichment facility in Pretoria, South Africa. During June 2023, the Company entered into a multi-year carbon-14 take-or-pay contract with a minimum revenue commitment of $2.5 million per annum. Processing the materials for the first batch of carbon-14 is expected to take approximately six months, with the Company still expecting to receive the first revenues from this contract during 1H 2024. The Company has also started the construction of its third isotope enrichment facility in Pretoria, South Africa. This third enrichment facility is expected to produce kilogram quantities of highly enriched Ytterbium-176, an important stable isotope used in the production of Lutetium-177. The Company aims to start commercial production of Ytterbium-176 during 2025. This new Ytterbium-176 enrichment facility will be the Company's first commercial plant to utilize Quantum Enrichment, an advanced isotope enrichment technique that is currently under development by ASP Isotopes and its energy subsidiary, Quantum Leap Energy, QLE.

08:33 EST Bit Digital upsizes contract with customer of its Bit Digital AI business line - Bit Digital announced that it has increased the scope of its contract with its first customer of its Bit Digital AI business line. Under the terms of the agreement, Bit Digital will supply the customer with computational power from an additional 512 GPUs for a period of three years. The total contract value with the customer for an aggregate of 2,048 GPUs is now worth more than $50M of annualized revenue to Bit Digital. To fulfill the contract, the Company has placed a purchase order for 64 servers manufactured by Super Micro Computer, an authorized Nvidia OEM, that are equipped with 512 Nvidia HGX H100 GPUs along with related equipment, which are expected to be delivered to the Company during January 2024. The servers will be deployed in Iceland at the datacenter where the Company's existing AI servers are located. As of the date of this press release, 128 AI servers have been successfully installed at the datacenter in Iceland and are undergoing testing. The remaining servers are expected to arrive at the datacenter during January. To help finance the growth of Bit Digital AI, the Company has executed a sale-leaseback agreement with a third party. Under the agreement, Bit Digital has agreed to sell the third party 96 AI servers, representing 768 GPUs, and lease them back for a period of three years. The lease rate represents a percentage of the total contracted rate for those GPUs and the Company will also pass through pro-rated operational expenses for those units to the third party.

08:19 EST VIctory Energy completes Victory Oilfield Tech, H2 Energy Group merger - Victory Clean Energy announces the completion of their definitive merger agreement, dated December 31, 2023, uniting VYEY formerly Victory Oilfield Tech and H2 Energy Group. The newly combined entity will operate under the name Victory Clean Energy, Inc. The merger positions Victory Clean Energy as a formidable player in the low-cost Green Hydrogen sector, focusing on decarbonization in heavy transportation and industrial Hydrogen markets. Leveraging Victory's exposure to public capital markets and H2EG's cutting-edge TrueGreen Hydrogen production solutions, the combined company aims to provide clean, reliable, and cost-effective energy sources to a diverse range of clients. The newly merged company is poised to realign its strategic focus, channeling efforts towards decarbonizing demanding industrial sectors through our TrueGreen Hydrogen production solutions.

08:16 EST NFT Gaming announces name change to Gaxos.AI - The NFT Gaming Company has changed its name from NFT Gaming Company to Gaxos.AI and its ticker symbol from "NFTG" to "GXAI". The Company expects that its shares of common stock will begin trading on The Nasdaq Stock Market under the new name and new stock ticker symbol "GXAI" in January 2024. The name change was approved at a meeting of the board of directors held on January 05, 2024.

08:15 EST SAIC to deliver IT services on Department of Veterans Affairs $60.7B contract - Science Applications Internationa has been selected to provide a range of Information Technology services on the Department of Veterans Affairs contracting vehicle called Transformation Twenty-One Total Technology Next Generation Two . "SAIC is ready to deliver best-in-class innovation and modernization in support of our nation's heroes, the veteran community," said Vishal Tulsian, senior vice president, Health, State and Local, and Federal Financials at SAIC. "We will continue to support the Department of Veterans Affairs in their pursuit of innovative IT services including highly secure and adaptable IT infrastructure, systems engineering, secure application development and customer support and training." Under this contract, companies selected will compete for task orders to provide a full range of IT services across 11 technical functional areas in support of the VA and other federal agencies. SAIC will serve as a prime contractor on the first position. On the second, the company will be a contractor in the joint venture with Higher Echelon, which is in a mentor-protege program with SAIC. SAIC has supported the VA's previous contracting vehicle and successfully executed 16 task orders valued at approximately $935 M, to date.

08:14 EST Akerna announces special meeting to vote on Gryphon Digital merger - Akerna Corp. announced that its special meeting of stockholders will be held on Monday, January 29, 2024, at 9:00 a.m., Mountain Time for consideration and voting on the proposed merger between Akerna and Gryphon Digital Mining, as well as certain other matters relating thereto. The record date for the determination of stockholders entitled to receive notice of and to vote at the Akerna Special Meeting is the close of business on December 21, 2023. Akerna's registration statement on Form S-4, filed with the U.S. Securities and Exchange Commission by Akerna was declared effective by the SEC on January 9, 2024. The Form S-4 was filed in connection with the previously announced Transaction. The Form S-4 serves as both a proxy statement of Akerna and as a prospectus. Stockholders of both Akerna and Gryphon are encouraged to read the proxy statement/prospectus which contains important information regarding the Transaction. Upon the closing of the Transaction, the common stock of the new "Gryphon Digital Mining, Inc." is expected to be listed on the Nasdaq under the proposed ticker symbol "GRYP." The closing of the Transaction remains subject to approval by both Akerna and Gryphon stockholders, final approval by the Nasdaq and customary closing conditions. Akerna and Gryphon are targeting to close the Transaction on January 31, 2024

08:14 EST Xeris license pact with $75M potential for Xeriject formulation of teprotumumab - Xeris Biopharma Holdings (XERS) announced that it has entered into an exclusive worldwide license agreement for Amgen (AMGN) to develop, manufacture, and commercialize a subcutaneous formulation of teprotumumab using Xeris' XeriJect technology in Thyroid Eye Disease a serious, progressive and potentially vision-threatening rare autoimmune disease. Teprotumumab-trbw is known as TEPEZZA in the United States. "We are very excited that our partner is moving forward with licensing the XeriJect technology to further the development of the XeriJect subcutaneous teprotumumab to potentially enhance the patient experience and delivery of the treatment for Thyroid Eye Disease. This agreement to license XeriJect further validates the potential value of our technology to enable large molecule subcutaneous injections that provide a more patient friendly regimen that is effective, safe, and more convenient, with potential for improved adherence," said Paul R. Edick, Chairman and CEO of Xeris. "We will move quickly to support our partner in this important development program." Under the terms of the License Agreement, Xeris has the potential to receive $75 M in development and regulatory milestones, plus sales-based milestones, as well as escalating single-digit royalties based on future sales of TEPEZZA using the XeriJect technology.

08:12 EST WiMi Hologram Cloud working on blockchain hashing algorithm - WiMi Hologram Cloud is working on the optimization of a blockchain hash algorithm based on proactive re-configurable computing architecture. PRCA is an operational mechanism based on multi-dimensional re-configurable functional structures, which centers on the execution structure of computation, and storage that changes dynamically with the efficiency when data is being processed, instead of improving the algorithms to improve the performance of the computation while the underlying hardware remains unchanged. PRCA has many functional equivalents, but they are accomplished by combining different hardware structures with that algorithm. The goal is to achieve high performance in computation, i.e., to deal with how the algorithm automatically senses variables to generate the optimal set of computations and re-configures the computation autonomously. In addition, PRCA can improve the processing efficiency of the blockchain by dynamically adapting the hardware configuration to different computational requirements. For example, when performing hash computing, the hardware configuration can be dynamically adjusted according to the actual computational needs, such as increasing the number of CPU cores, increasing the memory capacity, etc., in order to improve the speed of computing. WiMi is managing to apply PRCA to the blockchain to generate the optimal computational structure through self-awareness and dynamic selection, where all software and hardware are dynamically variable. During application processing, the optimal solution can be selected based on the independent variables in the program, and the optimal set of solutions with functionally equivalent variables with different computational efficiencies is obtained, which improves the performance of the hash algorithm, increases the transmission efficiency, and enhances the security of the blockchain.

08:11 EST Secoo Holding receives additional delinquency letter from Nasdaq - Secoo Holding Limited announced that on January 5, 2024, it received an additional delinquency letter from The Nasdaq Stock Market LLC, notifying the Company that (i) the Company is not in compliance with Nasdaq's continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1) due to the Company's failure to file its Form 6-K containing an interim balance sheet and income statement as of the end of its second quarter ended June 30, 2023, which serves as an additional basis for delisting the Company's securities from Nasdaq, and (ii) the Nasdaq Hearings Panel will consider this matter in rendering a determination regarding the Company's continued listing on Nasdaq. The Nasdaq additional delinquency letter has no immediate effect on the listing or trading of the Company's American Depositary Shares on Nasdaq.

08:08 EST Taysha Gene Therapies announces first pediatric patient dosed with TSHA-102 - Taysha Gene Therapies announced that the first pediatric patient has been dosed with TSHA-102 in the REVEAL Phase 1/2 pediatric trial in the United States evaluating the safety and preliminary efficacy of TSHA-102 in stage three female patients 5-8 years of age with Rett syndrome. The Company also announced the United Kingdom Medicines and Healthcare products Regulatory Agency, MHRA, has authorized the Clinical Trial Application, CTA, for TSHA-102 in pediatric patients, enabling expansion of the ongoing U.S. REVEAL pediatric trial into the U.K. "Dosing the first pediatric patient with Rett syndrome marks an important step forward in our efforts to broaden the clinical evaluation of TSHA-102 to younger patients with earlier stages of Rett syndrome. We are pleased with our progress on expanding the study of TSHA-102 across a broad population of ages and stages of Rett syndrome to bring a potentially transformative treatment option to all patients and families suffering from this devastating disease," said Sukumar Nagendran, M.D., President, and Head of R&D of Taysha. "The pediatric trial will build on our ongoing REVEAL adolescent and adult trial, where early data demonstrated improvements across multiple clinical domains in adult patients with the most advanced stage of disease. We also plan to expand our U.S. pediatric trial into the U.K. following the recent acceptance of our CTA by the MHRA."

08:07 EST Cerence selected by Great Wall Motor to power in-car experience - Cerence (CRNC) announced that Great Wall Motor Company (GWLLF), GWM, one of China's largest SUV, pickup, and electric vehicle manufacturers, has selected Cerence to power the in-car experience across its lineup as it expands worldwide. GWM will deploy this new, Cerence-powered user experience in 13 languages across 20 countries in key car models, including the GWM TANK300, GWM TANK500, ORA 07, and POER, bringing intuitive, natural interaction to drivers globally. GWM and Cerence have collaborated to bring new, enhanced user experiences to GWM drivers. GWM is leveraging Cerence Assistant and Cerence Speech Signal Enhancement to provide key features, including wake-up word activation; support for multi-step interactions; and multi-zone interaction, meaning drivers and passengers can both engage with the assistant and receive support specified to their seat and needs. "Great Wall Motor's success in China serves as a strong foundation for success globally as it expands worldwide and brings new electric models to market," said Stefan Ortmanns, CEO, Cerence. "By empowering drivers with intuitive, intelligent voice interaction, GWM will advance its mission of accelerating innovation that serves a global consumer base. We are proud to be part of GWM's global success."

08:05 EST Akoya Biosciences announces establishment of Scientific Advisory Board - Akoya Biosciences announced the establishment of its Scientific Advisory Board to provide strategic guidance and consult on the Company's efforts to deliver spatial biology solutions for the life sciences industry, from discovery to diagnostics. The initial members of Akoya's Scientific Advisory Board are: Garry Nolan, Ph.D., Rachford and Carlota Harris Professor in the Department of Pathology at Stanford University School of Medicine, co-founder of Akoya Biosciences and inventor of the CODEX technology. James Allison, Ph.D. Padmanee Sharma, M.D., Ph.D. Jeanette Hsu.

08:04 EST Semantix CFO Adriano Alcade resigns - Semantix announces the resignation of Mr. Adriano Alcalde, CFO, to be effective on May 1, 2024. Mr. Alcalde has served as CFO & IR of the Company since June 2020, contributing significantly to its financial success and growth. The Company is committed to ensuring a seamless transition and has already initiated a thorough search for a qualified successor. During this interim period, Mr. Alcalde will work closely with the executive team to facilitate a smooth handover of responsibilities. The Board of Directors and executive leadership team are actively engaged in the succession planning process, and updates on the progress will be communicated promptly to stakeholders. The company remains focused on its strategic objectives and is optimistic about the future.

08:04 EST Labcorp, Hawthorne Effect announce collaboration - Labcorp and Hawthorne Effect are pleased to announce a strategic collaboration to advance decentralized clinical trial capabilities for pharma, biotech and medical device sponsors seeking to increase patient diversity and inclusion, decrease site burden, and accelerate enrollment and clinical study timelines. Through the collaboration, Labcorp and Hawthorne Effect aim to combine their services and create new, differentiated service offerings to support decentralized clinical trials. Hawthorne Effect's comprehensive digital platform allows complex study visits and clinical data collection to be conducted seamlessly in the patient home or community and has been demonstrated to increase diverse patient participation, improve quality, completeness and timeliness of trial data, and accelerate trial timelines.

08:03 EST Bone Biologics regains compliance with Nasdaq continued listing rule - Bone Biologics announced that it has received notice from The NASDAQ Stock Market informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Bone Biologics is now in compliance with all applicable listing standards and its common stock will continue to be listed on The Nasdaq Capital Market, but will remain under Nasdaq's discretionary panel monitor until June 28. Bone Biologics was notified by Nasdaq on September 27, that it was not in compliance with the minimum bid price rule because its common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive business days. In order to regain compliance with the Rule, the Company was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days. This requirement was met on January 4, the 10th consecutive trading day when the closing bid price of the Company's common stock was over $1.00.

08:02 EST Mirati Therapeutics receives conditional authorization for KRAZATI from EC - Mirati Therapeutics announced that the European Commission, or EC, granted conditional marketing authorization for KRAZATI, or adagrasib, as a targeted treatment option for adult patients with KRASG12C -mutated advanced non-small cell lung cancer, or NSCLC, and disease progression after at least one prior systemic therapy. KRAZATI has demonstrated a positive benefit-risk profile based on the Phase 2 registration-enabling cohort of the KRYSTAL-1 study, evaluating KRAZATI 600 mg administered orally twice daily in 116 patients with KRASG12C-mutated advanced NSCLC who previously received treatment with a platinum-based regimen and an immune checkpoint inhibitor. The primary efficacy endpoints were confirmed ORR and DOR as evaluated by blinded independent central review according to response evaluation criteria in solid tumors. Conditional marketing authorization for KRAZATI is valid in all 27 EU member states plus Iceland, Norway and Liechtenstein. This authorization follows the positive opinion adopted by the Committee for Medicinal Products for Human Use in November 2023.

07:59 EST Taseko Mines produced 34M pounds of copper in Q4 - Taseko Mines announced that the Gibraltar mine produced 34M pounds of copper and 369,000 pounds of molybdenum in the Q4. For the full year, Gibraltar produced 123M pounds of copper, well above guidance and 26% higher than the previous year. Copper production in the Q4 was supported by strong copper grades of 0.27% with ore from the lower benches of the Gibraltar pit. Mill throughput in the quarter averaged 83,000 tons per day and was impacted by additional downtime for maintenance and monitoring of the ball mill in concentrator #2. Copper sales volumes in the Q4 were 36M pounds, and year-end concentrate inventories remained above normal levels.

07:51 EST Fairfax Financial acquires additional Orla Mining shares - Fairfax Financial Holdings (FRFHF) has acquired, through its insurance company subsidiaries, 500,000 common shares of Orla Mining (ORLA) at a price of $4.20 per Common Share for an aggregate purchase price of approximately $2,100,000 through the facilities of the Toronto Stock Exchange. The Share Purchase represents approximately 0.16% of the issued and outstanding Common Shares of Orla and brings Fairfax's total holdings, through its insurance subsidiaries, of such securities to 40,367,191 Common Shares. Immediately prior to the Share Purchase, Fairfax, through its insurance company subsidiaries, beneficially owned and controlled 39,867,191 Common Shares, representing approximately 12.68% of the issued and outstanding Common Shares of Orla.

07:38 EST Else Nutrition RTD Kids Shakes available on Canadian online retail platform - Else Nutrition announces that its new Ready-to-Drink, RTD, Kids Shakes are now available on one of Canada's largest online retail platforms in both Vanilla and Chocolate flavors. "Launching our RTD Kids Shakes on this major online platform marks an important milestone in our mission to offer healthy and delicious nutritional products to Canadian families nationwide," said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. "We are proud to collaborate with this large retailer and believe this is an important step towards offering our products in their stores across North America. Given the positive feedback from consumers, as well as the significant traction we are witnessing in the market, we believe we are well positioned to leverage this relationship to increase market share and assist in accelerating our growth."

07:36 EST Associated Capital reports preliminary Q4 book value per share $41.91-$42.11 - Associated Capital Group announced a preliminary range for its fourth quarter book value of $41.91 to $42.11 per share. This compares to $41.43 per share at September 30, 2023 and $40.48 per share at December 31, 2022.

07:35 EST Jushi Holdings announces opening of relocated dispensary in Pennsylvania - Jushi Holdings announced the opening of its relocated Beyond Hello Hazleton dispensary in Pennsylvania, through its subsidiary, Franklin Bioscience - NE LLC. Franklin Bioscience - NE LLC's new store, doing business as Beyond Hello Mount Pocono, is located at 3192 Route 940, Suite 101, in Monroe County, and ideally situated directly in the Pocono Mountains, a bustling vacationing area full of various outdoor activities, resorts, shopping, and entertainment. The dispensary will begin serving medical cannabis patients and caregivers in Northeast Pennsylvania and beyond on Saturday, January 13th, at 9:00 a.m., and will offer an exclusive promotion of 30% off all purchases that same day. Beyond Hello Mount Pocono will be open daily Monday through Saturday from 9:00 a.m. to 8:00 p.m. and on Sundays from 10:00 a.m. to 6:00 p.m.

07:34 EST BridgeBio reports inducement grants under Nasdaq listing rule - BridgeBio Pharma announced that on January 08, 2024, the compensation committee of BridgeBio's board of directors granted twenty five new employees restricted stock units for an aggregate of 66,963 shares of the Company's common stock. One-fourth of the shares underlying each employee's restricted stock units will vest on February 16, 2025, with one-twelfth of the remaining shares underlying each such employee's restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee's continued employment with the Company or one of its subsidiaries on such vesting dates. All of the above-described awards were made under BridgeBio's Amended and Restated 2019 Inducement Equity Plan. The above-described awards were each granted as an inducement material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted pursuant to the terms of the Plan. The Plan was adopted by BridgeBio's board of directors in November 2019, and amended and restated on February 10, 2023 and on December 13, 2023.

07:33 EST Lilium, Fraport collaborate on development of commercial eVTOL network - Airport operator Fraport and Lilium announced their strategic collaboration to explore required planning and approval steps for state-of-the-art infrastructure for the implementation of commercial eVTOL operations at airports. Fraport is active at 30 international airports across four continents. The partnership will start by preparing Germany and the industry for the introduction of regional electric air mobility through working with industry groups and the German government to jointly discuss and accelerate necessary regulatory work. Fraport and Lilium plan to analyze future mobility concepts for vertiport networks that are suitable for electric aircraft. Fraport and Lilium will also examine how future vertiport concepts for this type of mobility could look like, especially at and around airports. Lilium CEO Klaus Roewe highlights: "With Fraport, we have partnered with one of the most renowned international airport operators in the world. Through this partnership, we expect to be able to analyze the conditions for regional aviation with electrically powered and quiet jets. Our goal is to jointly advance regulatory and practical steps for suitable framework conditions for electric aviation and our potential customers in Germany and Europe."

07:32 EST PharmaTher provides update for expected FDA approval of ketamine - PharmaTher Holdings provides an update for the Company's lead drug, ketamine, as a potential treatment for anesthesia, sedation, pain, mental health, and neurological indications. On September 27, 2023, the Company announced that the U.S. Food and Drug Administration had accepted the priority original Abbreviated New Drug Application for ketamine and assigned an approval goal date of April 29, 2024. The assigned FDA approval goal date is still on track. Fabio Chianelli, CEO of PharmaTher, commented: "We believe 2024 will be a transformative year for PharmaTher with the expected FDA approval of ketamine having an assigned goal date for approval on April 29, 2024. In anticipation of a potential FDA approval, we are focusing on the commercial scale-up of ketamine in the U.S. and seeking additional international approvals." Ketamine has been on the FDA's drug shortage list since February 2018, which is believed to have encouraged the widespread availability of compounded ketamine products not FDA approved for psychiatric disorders. On October 10, 2023, the FDA published a compounding risk alert describing the potential risks associated with compounded ketamine products for psychiatric disorders, specifically from telehealth providers that provide in-home ketamine services. These compounded ketamine products are not FDA approved. The Company's overall goal is to solve the ketamine shortage problem in the U.S. and anticipates the commercial launch of ketamine in 2024, and will meet the FDA's strict manufacturing guidelines and FDA-approved prescribing label. KETARX will be produced in the U.S. in a cGMP manufacturing facility that is DEA certified and inspected by domestic and international regulatory agencies, including the FDA and EU EMA. Following the FDA approval and launch in the U.S., the Company will pursue international approvals to support the global demand for ketamine. Ketamine is an essential medicine used for anesthesia and analgesia listed on the WHO Essential Medicines List. In Canada, ketamine has been classified as a Tier 3 drug shortage since February 2023, and Health Canada has approved ketamine for use as a sedative and painkiller in hospital settings. Outside of the FDA and Health Canada approved indications, ketamine is also being administered in hospitals and clinics to treat various mental health, neurological and pain disorders. A recently published new peer-reviewed study on the real-world effectiveness of ketamine intravenous therapy demonstrated significant patient improvement for depression, anxiety and suicidal ideation. The Company's long-term strategy is pursuing novel uses and delivery methods of ketamine as a potential treatment for pain, mental health, and neurological disorders. In anticipation of a potential FDA approval for ketamine, the Company will allocate funds to the U.S. commercial scale-up and international regulatory approvals, and pause funding for its product and clinical programs, including its microneedle patch and on-body pump systems, Parkinson's disease, Amyotrophic Lateral Sclerosis, Rett Syndrome, and Complex Regional Pain Syndrome for the first half of 2024. The Company will evaluate these programs quarterly to determine a potential rationale for reviving one or more of them internally or with potential pharmaceutical partners.

07:31 EST FirstService adds restoration tucker-under acquisitions - FirstService Corporation announced that it has recently completed three restoration tuck-under acquisitions. Terms of the transactions were not disclosed. First Onsite Restoration acquired Dayton, Ohio-based DryPatrol LLC. Paul Davis Restoration added to its company-owned platform by acquiring two of our existing franchised operations, one of which serves the Denver, Colorado metropolitan area. "These additions reflect our ongoing commitment to invest in key markets which are susceptible to weather-related property and large loss claims," said Scott Patterson, Chief Executive Officer of FirstService. "We are excited to work with the management teams to capitalize on our future opportunity in these markets."

07:27 EST Rapid Micro announces availability of Growth Direct Rapid Sterility application - Rapid Micro Biosystems expects the commercial launch of the Growth Direct Rapid Sterility application by mid-year 2024. Sterility testing is the final quality check for microbial contamination before a pharmaceutical product is released for commercial sale and is typically performed in a facility that manufactures products such as biologics or sterile injectables. The Company has developed a novel, proprietary Rapid Sterility application for use with its Growth Direct system. This innovative solution delivers time to organism detection in as little as 12 hours and final time-to-result in as little as one to three days. This capability represents a significant improvement over widely used traditional test methods, which generally require a 14-day endpoint incubation, and provides compelling differentiation when compared to current rapid sterility products. Commercial launch of the Growth Direct Rapid Sterility application is expected by mid-year 2024.

07:21 EST Fury Gold Mines appoints Phil van Staden as CFO - The Company announced the appointment of Phil van Staden, the current Interim CFO of the Company, to the position of CFO, effective as of January 1, 2024. Mr. van Staden joined Fury in 2020 and brings over 15 years of diverse international experience in various accounting roles and industries throughout South Africa and Canada.

07:17 EST Mayfair Gold announces results from Footwall Zone at Fenn-Gib - Mayfair Gold announced further results from the higher-grade Footwall Zone located approximately 100 meters to the northwest of the Fenn-Gib gold deposit. Mayfair's 100% controlled Fenn-Gib Project, located in the Timmins region of Northeast Ontario, hosts a NI 43-101 open-pit constrained Indicated mineral resource estimate of 3.38 million ounces gold at a grade of 0.93 grams per tonne Au and an Inferred mineral resource of 0.16Moz Au at 0.85 g/t Au. The near-surface Fenn-Gib gold mineralization is broadly disseminated striking east-west on the Pipestone Fault over more than 1.5 kilometers, and is over 500m wide at the west end. Highlight drill results include: FG23-351 intersected 2.19 g/t Au over 16.8m, including 3.28 g/t Au over 7.0m and 3.21 g/t Au over 2.0m; FG23-353 intersected 2.10 g/t Au over 16.0m, including 4.07 g/t Au over 3.0m; FG23-359 intersected 27.60 g/t Au over 2.1m, 3.64 g/t Au over 5.0m and 3.70 g/t Au over 3.2m; FG23-361 intersected 16.47 g/t Au over 2.3m; FG23-366 intersected 6.23 g/t Au over 2.9m, including 15.80 g/t Au over 0.9m; and FG23-368 intersected 3.14 g/t Au over 10.0m including 15.94 g/t over 1.0m. The latest drill results continue to intersect significant gold mineralization building on Mayfair's previously reported Footwall Zone drill results that included: hole FG21-139 intersected 1.94 g/t Au over 38.0m, including 4.06 g/t Au over 15.0m. FG21-166 intersected 1.42 g/t Au over 66.0m, including 3.4 g/t Au over 19.2m, including 6.20 g/t Au over 9.2m. A lower zone in hole FG21-166 returned 1.02 g/t Au over 34.0m, including 11.49 g/t Au over 1.0m; FG21-170 intersected 37.51 g/t Au over 2.6m and 59.05 g/t over 1.0m; hole FG21-186 intersected 2.31 g/t Au over 30.0m, including 6.58 g/t Au over 7.0m. FG21-188 intersected 25.93 g/t Au over 1.5m, 1.37 g/t Au over 25.5m including 5.4 g/t Au over 5.0m; FG21-203 intersected 2.70 g/t Au over 15.0m; including 4.04 g/t Au over 9.0m, including 7.18 g/t Au over 4.0m; FG21-215 intersected 2.88 g/t Au over 49.0m, including 6.53 g/t Au over 17.5m and FG22-218 intersected 0.71 g/t Au over 92.0m, including 2.15 g/t Au over 10.0m. A lower zone returned 2.40 g/t Au over 47.4m, including 3.83 g/t Au over 4.7m and 5.26 g/t Au over 6.6m and 6.78 g/t Au over 7.0m. FG23-300 intersected 2.05 g/t Au over 16.2m, including 3.72 g/t Au over 6.2m, and hole FG23-328 returned 15.65 g/t Au over 1.5m and 7.94 g/t Au over 7.0m and hole FG23-344A intersected 4.72 g/t Au over 30.0m, including 6.59 g/t Au over 19.6m. FG23-304 intersected 1.46 g/t Au over 25.9m, including 14.32 g/t Au over 1.0m and 3.0 g/t Au over 3.5m and 5.88 g/t Au over 1.9; FG23-314 intersected 2.19 g/t Au over 17.1m, including 13.67 g/t Au over 2.0m; FG23-326 intersected 3.67 g/t Au over 8.0m, including 6.47 g/t Au over 4.2m including 19.89 g/t Au over 0.9m and FG23-345 intersected 1.44 g/t Au over 49.5m, including 9.20 g/t Au over 2.5m and 2.92 g/t Au over 3.0m. The Footwall Zone target consists of multiple mineralized zones hosted primarily in the footwall mafic volcanic assemblage, located immediately northwest of the Fenn-Gib gold deposit. The Footwall Zone strikes in a northeasterly direction and with a steep northerly dip. Mineralization consists of bleached, buff-altered, pillowed mafic volcanic with pyrite ranging from 2% to over 20%. Metallurgical tests conducted on a Footwall Zone underground sample showed excellent metallurgy. Whole-ore cyanidation confirmed high gold recovery of 94.2% at a P80 59um grind size and 48-hour leach time.

07:15 EST Xtract One partners with H-E-B Center at Cedar Park - Xtract One Technologies announced its SmartGateway system has been selected to protect all entrances of H-E-B Center at Cedar Park, a 8,000-capacity multi-purpose entertainment facility in Central Texas. Xtract One's SmartGateway system replaces traditional metal detectors and delivers screening solutions for large, ticketed venues to allow for high throughput. "We are thrilled to partner with H-E-B Center at Cedar Park to provide our advanced security solution to help improve patron safety and enhance the existing security measures," said Peter Evans, CEO of Xtract One. "This collaboration marks a significant step in advancing and modernizing venue security, all while prioritizing the overall patron experience. Our goal is to help create an even more secure and memorable entertainment space for anyone going to the venue."

07:13 EST Revive completes development of lyophilized formulation of bucillamine - Revive Therapeutics has completed the formulation development work of the Company's next-generation lyophilized formulation of Bucillamine conducted at the University of Waterloo. The New Bucillamine has the potential to unlock the therapeutic utility of Bucillamine for treating public health medical emergencies, including pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. Key research findings and observations include: Lyophilization of Bucillamine enhances solubility 2.7x compared to standard solution of Bucillamine; Inclusion of lyophilization in the Bucillamine formulation approach can result in an ability to increase Bucillamine delivery per dosing unit; and Inclusion of lyophilization in the Bucillamine formulation approach offers a simple way to create a parenteral injection product with minimal formulation additives. With this achievement, Revive will work with Attwill Medical Solutions LP in the technology transfer and prepare plans for potential clinical and commercial development in support of specific initiatives that the Company is involved with, such as the continuation of the research project the Company has with the Defence R&D Canada - Suffield, an agency of the Canadian Department of National Defence, to evaluate Bucillamine as a potential treatment for nerve agent exposure. Also, the Company may explore the New Bucillamine as a potent antioxidant and anti-inflammatory, for rare inflammatory disorders such as ischemia-reperfusion injury, which the FDA granted orphan drug designation for in 2022. The Company expects to have New Bucillamine ready for clinical evaluation in 2024.

07:11 EST U.S. Energy announces completion of asset divestitures - U.S. Energy announced it had completed a series of non-core asset divestitures. HIGHLIGHTS: All-cash proceeds of approximately $7.2 million; Divested assets averaged approximately 200 barrels of oil equivalent per day from July-September 2023, or 12% of USEG total production over the same period; All proceeds used to reduce existing debt, leaving USEG materially debt-free; No changes to the Company's existing $20.0 million borrowing base; Represents the majority of USEG's non-operated assets. "Throughout the fourth quarter, we executed on a series of asset divestitures representing the majority of U.S. Energy's non-operated assets," stated Ryan Smith, Chief Executive Officer of U.S. Energy Corp. "The assets divested represent legacy USEG properties, primarily in current non-core focus areas, and will allow the Company to realize immediate additional corporate overhead savings. With proceeds going directly towards debt reduction, U.S. Energy now sits in a position of increased liquidity across all measures and meaningful portions of our 2024 oil production hedged at an average price in the low $80's. As we enter 2024, we look forward to focusing our capital allocation efforts on the Company's highest rate of return growth initiatives, maintaining a strong balance sheet, and driving shareholder returns."

07:10 EST Canoo created 100 jobs in Oklahoma to scale EV manufacturing - Canoo announced the company has created over 100 new jobs in the state of Oklahoma and achieved a key hiring milestone. The state is now home to 20% of Canoo's total workforce. As Canoo scales manufacturing to make additional customer deliveries in 2024, the company is continuing to build the team of skilled workers at both its Oklahoma City vehicle manufacturing facility and also at its battery module assembly facility in Pryor. This announcement follows Canoo's recent acquisition of manufacturing assets to increase its vehicle assembly capacity. The company is growing its team across Oklahoma to scale manufacturing and meet customer deliveries of 18,000 committed orders representing $750M in revenue over multiple years. Oklahomans make up over 90% of the Canoo team in Oklahoma, and military veterans and Native Americans each make up about 10% of Canoo's workforce in the state. Canoo's Oklahoma City manufacturing workforce is earning annual wages about 37% above the local average for similar roles in the Oklahoma City metropolitan area. With about 30 open positions in the state, the company is continuing to build its workforce with the help and support of partners, including Express Employment Professionals, Canadian Valley Technology Center, Atlas School, Oklahoma Department of Commerce, Cherokee Nation, and Pawnee Nation.

07:08 EST Climb Channel announces expanded partnership with Jamf Holding - Climb Channel Solutions, wholly owned subsidiary of Climb Global Solutions (CLMB) has expanded their partnership with Jamf (JAMF), the standard in managing and securing Apple at work, to their US offerings. This partnership, which has already seen success in Canada, empowers businesses to efficiently manage and secure their Apple devices, ensuring seamless integration, enhanced productivity, and streamlined workflows. With Jamf's cutting-edge software solutions and Climb Channel Solutions' extensive network and distribution capabilities, partners can access comprehensive support, training, and deployment options, resulting in optimized IT infrastructure and a superior end-user experience. "We are excited to expand our partnership with Jamf, a true industry leader in Apple device management and security," says Dale Foster, CEO of Climb Channel Solutions. "After the success of our partnership in Canada, it was apparent that our US partners would benefit from how Jamf is transforming the way businesses manage and secure their Apple devices, enabling streamlined workflows, enhanced productivity, and unmatched user experiences. Our continued and expanding partnership with Jamf remains a testament to our commitment to delivering innovative technology solutions and empowering organizations to thrive in the digital age."

07:07 EST Aclaris announces Phase 2b study of ATI-1777 met primary efficacy endpoint - Aclaris Therapeutic announced top-line results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to severe atopic dermatitis). ATI-1777 was generated from Aclaris' proprietary KINect drug discovery platform. Results: The trial met the primary efficacy endpoint, the percent change from baseline in the Eczema Area and Severity Index score at week 4, with statistical significance for patients treated with ATI-1777 2% BID compared to patients treated with vehicle. In addition, the following results were observed with respect to the primary endpoint: While not statistically superior, ATI-1777 2% QD showed a trend toward significance; In the per-protocol population, or all patients who had week 4 data with no major protocol deviations, ATI-1777 2% BID demonstrated a 70.8% reduction in EASI compared to a 58.5% reduction in vehicle, and ATI-1777 2% QD demonstrated a 68.4% reduction in EASI compared to a 59.7% reduction in vehicle. In addition, a post-hoc analysis of only patients who had baseline severity of moderate or severe AD showed a 65.6% and 65.1% reduction in the EASI score at week 4 in ATI-1777 2% BID and ATI-1777 2% QD, respectively, compared to a 52.6% reduction in the pooled vehicle group. While not statistically powered, ATI-1777 2% BID and 2% QD also showed improvement in the proportion of patients who reached an IGA-TS response at week 4. The per-protocol population demonstrated an IGA-TS response at week 4 of 41.8% for ATI-1777 2% BID compared to 25.5% in vehicle and 39.8% for ATI-1777 2% QD compared to 25.4% in vehicle. A PK analysis showed minimal levels of exposure to ATI-1777. The mean steady state trough drug levels at week 4 were 0.319 ng/mL, representing 0.7% of IC50 for JAK 1/3 inhibition in whole blood. In total, 97% of ATI-1777 plasma samples from dosed patients had concentrations below 1/10th of the IC50, and six samples of 570 samples analyzed had concentrations above 1/4 of the IC50. No meaningful safety findings were observed and ATI-1777 was well tolerated.

07:06 EST Amazon announces 'Buy with Prime' integration with 'Salesforce Commerce Cloud - Amazon (AMZN) announced the Buy with Prime for Salesforce (CRM) Commerce Cloud integration. This solution helps Salesforce merchants seamlessly integrate Buy with Prime into their existing shopping experience. Buy with Prime for Salesforce also offers merchants several new features, including the ability for shoppers to search and filter for Prime eligible items, and purchase Prime eligible and other items in the same order. This integration helps Salesforce merchants connect with new shoppers and increase conversion by offering the convenient shopping benefits of Prime, including fast, free delivery, a trusted checkout experience, 24/7 live chat support, and hassle-free returns. Buy with Prime for Salesforce will start rolling out today as invitation only to select Salesforce merchants, and it will be available to all U.S.-based Salesforce Commerce Cloud merchants via the Salesforce AppExchange later this year. "The Buy with Prime integration with Salesforce Commerce Cloud empowers merchants to offer their shoppers a new yet familiar purchasing option directly within their digital storefronts," said Peter Larsen, Amazon vice president of Buy with Prime. "Now with new features that build Buy with Prime seamlessly into search, cart, and checkout, Salesforce merchants have even more flexibility and functionality to provide Buy with Prime while maintaining control over their stores' look and feel." "Buy with Prime for Salesforce Commerce Cloud builds on our efforts to help ecommerce businesses drive profitable growth and superior shopping experiences," said Michael Affronti, Salesforce senior vice president and general manager of Commerce Cloud. "As companies look to scale and drive brand loyalty among new and returning shoppers, Buy with Prime offers Salesforce merchants a powerful tool to attract millions of Prime members and grow their businesses through the trusted Prime shopping experience."

07:04 EST Amarin on track to deliver $40M of annual savings from reduction in force - Amarin continues to make progress on reducing operating expenses and managing its cash position and is on-track to deliver $40 million of annual savings based on the reduction in force announced in July 2023. With the recent cash preservation initiatives, Amarin reiterates its belief that current cash and investments and other assets are adequate to support continued operations including the share repurchase program. We will continue to focus on cash preservation and prudently invest in the right opportunities which are value additive.

07:04 EST Amarin plans to initiate share repurchase program up to $50M - On January 9, 2024, Amarin entered into a conditional share repurchase agreement with Cantor Fitzgerald & Co. ("Cantor") to purchase up to $50 million of Amarin's ordinary shares held in the form of American depository shares (ADSs). The implementation of the share repurchase program will require Amarin shareholder approval as well as UK High Court approval, as required under UK company law. The Company intends to call its 2024 annual general meeting of shareholders early in the second quarter of 2024 to seek shareholder approval of the program, which would be followed by the UK High court process. Amarin anticipates that these steps could be completed by the end of the second quarter of 2024, with share repurchases commencing shortly thereafter.

07:03 EST TG Therapeutics reports preliminary FY23 BRIUMVI U.S. revenue $89M - Year-end 2023 cash position of approximately $215 million

07:02 EST Ceva and Sunplus technology expand collaboration - Ceva and Sunplus Technology, a chip provider for multimedia and automotive applications, announced the companies have expanded their collaboration to integrate Ceva's latest generation RivieraWaves Bluetooth audio solution into the Sunplus airlyra family of HD audio processors targeting wireless speakers, soundbars and other premium wireless audio devices. The first wireless airlyra processors are already shipping with some of the world's premium audio brands.

06:20 EST Nauticus Robotics secures funding, promotes John Gibson Jr. to interim CEO - Nauticus Robotics announced that it secured an investment before the close of 2023 and eliminated many of the dilutive warrants and ratchet provisions of the original de-SPAC financing in the process. The new investment is the first tranche of financing led by existing investors. Nauticus anticipates executing a second tranche of investment, discussions for which are ongoing and aimed at providing funding for the year. This includes the engagement of a new executive management team, culminating in the promotion of John Gibson Jr. to interim CEO on January 4, 2024.

06:10 EST VinFast Auto announces U.S. rollout of DrgnFly electric bike at CES 2024 - VinFast Auto announced the U.S. rollout of the DrgnFly electric bike, at CES 2024. The VinFast Drgnfly launches in the U.S. market with prices expected to start from $2,800, accompanied by a two-year and unlimited mileage warranty. The electric bike is expected to debut in other global markets in the near future.

06:05 EST Lifezone Metals signs agreement for Phase 1 for recycling project - Lifezone Metals CEO, Chris Showalter, announced the signing of the Subscription Agreement and completion of funding for Phase 1 of the joint venture with a wholly owned subsidiary of Glencore for a platinum, palladium and rhodium, collectively platinum group metals or "PGMs", recycling project which will utilize Lifezone Metals' hydrometallurgical technology. Phase 1 of the joint venture implementation is already underway and involves a confirmatory program of pilot work in Lifezone Metals' laboratories in Perth, Australia. Following successful completion of Phase 1, Phase 2 will involve Lifezone Metals and Glencore jointly funding the capital expenditures required to construct a commercial-scale PGM recycling facility in the U.S. The signing of the Subscription Agreement, along with the completion of Phase 1 funding, means the estimated $3M required for the confirmatory pilot project cost has now been finalized. Lifezone Metals and Glencore have contributed $1.5M each to the project. Phase 1 is expected to be completed in the first half of 2024.

06:02 EST Comstock Mining receives permit for its solar panel recycling facility in Nevada - Comstock announced that it has been notified by the Nevada Division of Environmental Protection of the issuance of the new Class II Air Quality Operating Permit for its Solar Panel Recycling Facility. The substantial majority of U.S. solar panels have been deployed in the southwest region of U.S., primarily California, Nevada, and Arizona with a remarkable acceleration of the decommissioning of these end-of-life solar panels occurring now. Comstock is currently building a facility that includes technologies for efficiently crushing, conditioning, extracting, and recycling metal concentrates from photovoltaics and other electronic devices. Comstock continues to secure supplier commitments, with sufficient existing commitments to begin commissioning of the facility and commencement of revenues upon receipt of the required permits and approvals. Comstock has received the required county permission and Class II Air Quality Operating Permit. Issuance of the final remaining Nevada Solid Waste Material Recovery Facility Permit is expected this quarter, thereby enabling Comstock to complete the installation of the process equipment and solicit the County Fire Marshall and Building Department to provide the final facility certificate of operation. Comstock Metals objectives for 2024 include receiving the final permit early this year, completing commissioning of photovoltaic material recycling, commencing production, continued expansion of our existing revenue generating supply commitments, and then finalizing the design and site selection for our first "industry-scale" production facility.

05:48 EST STMicroelectronics announces new product groups organization - STMicroelectronics announced its new organization, effective February 5. "We are re-organizing our Product Groups to further accelerate our time-to-market and speed of product development innovation and efficiency. This will enable us to increase value extraction from our broad and unique product and technology portfolio. In addition, we are getting even closer to our customers with an application marketing organization by end market which will boost our ability to complement our product offering with complete system solutions" said Jean-Marc Chery, President and CEO of STMicroelectronics. "This is an important step in the development of our established strategy, in line with our value proposition to all stakeholders and with the business and financial ambitions we set back in 2022". To complement the existing Sales & Marketing organization, a new application marketing organization by end market will be implemented across all ST Regions. This will provide ST customers with end-to-end system solutions based on the Company's product and technology portfolio. The company is implementing an application marketing organization by end market across all ST Regions, as part of its Sales & Marketing organization led by Jerome Roux, ST President and member of the Executive Committee.

05:27 EST InterDigital renews patent license agreements with Panasonic - InterDigital (IDCC) announced that the company has renewed its patent license agreements with Panasonic (PCRFY). The renewals extend Panasonic's license under InterDigital's HEVC patents and also extend its digital TV license under InterDigital's joint licensing program with Sony (SONY).